1 January 2019 in Urology Research and Practice
Objective: This study was designed to evaluate the prevalence of Human Papilloma Virus (HPV) in semen and document the cycle outcomes in couples with previous intra-cytoplasmic sperm injection (ICSI) failures. Material and methods: One hundred and seventeen couples with at least two ICSI attempts were included in the study. HPV infection in semen and DNA fragmentation in samples were analyzed by commercially available kits. The percentage of spermatozoa with fragmented DNA (DNA fragmentation index: DFI) was determined during fluorescence microscopic examination as previously described. The cycle outcomes of couples with or without HPV infected male partners were recorded. Results: According to our results, the prevalence of HPV was 7.7% in asymptomatic males with at least two previous ICSI failures. The increased DFI (>30%) was observed in 82.9% of the cases. In HPV-positive cases significantly lower number of good quality embryos were obtained. The implantation and pregnancy rates were similar in infected and non-infected males (p>0.05). The early miscarriage rate was slightly higher in HPV- positive group (33% vs. 10%, p>0.05). Conclusion: In cases with previous ICSI failures, the prevalence of HPV infection in semen is not higher than previously reported infertile populations. The reproductive outcome might be impaired in HPV-positive semen due to lower number of good quality embryos, which needs to be clarified by further large population-based studies. Cite this article as: Tangal S, Taşçı Y, Pabuçcu EG, Çağlar GS, Haliloğlu AH, Yararbaş K. DNA fragmentation index and human papilloma virus in males with previous assisted reproductive technology failures. Turk J Urol 2019; 45(1): 12-6.
3 September 2019 in The European Research Journal
Objectives: Aim of this study was to explore the effects of three months oral anti-oxidant treatment in normozoospermic men with high DNA fragmentation index (DFI) and recurrent intracytoplasmic sperm injection (ICSI) failures. Methods: This is a retrospective analyses of normozoospermic patients with high DFI levels (> 30%) with at least two unsuccessful ICSI attempts. Among the participants, the study group included men who had oral anti-oxidant treatment. The men who did not receive any treatment during the study period were taken as controls. The outcomes of new ICSI cycles were compared.Results: During the study period 24 men have used three months of oral anti-oxidant treatment before a new ICSI cycle whereas the remaining 46 had ICSI-only without any other intervention. Duration of stimulation, the number of metaphase II oocytes, fertilization rate and implantation rates were similar between two groups. Although not statistically significant, cases in anti-oxidant group have slightly better pregnancy rates compared to ICSI-only group (37.5% vs 19.6%, p > 0.05). Only one case in each group had abortion. Conclusions: This study reveals that there is no statistically significant difference in the ICSI outcomes of the patients with high DFI levels, following unsuccessful ICSI attempts after oral anti-oxidant treatment. The possible benefit derived from the anti-oxidant therapy needs to be clarified with clinical studies with greater study populations.
1 July 2021 in Acibadem Universitesi Saglik Bilimleri Dergisi
Purpose: Testicular tumor is the most common cancer among the young adult men. Although the undescended testicle is the most common cause which increases the risk of testicular tumor, the testicular cancer diagnosis of any of the first degree relatives, in situ germ cell neoplasia of the other testicle and the testicular dysgenesis syndrome are also included in the etiology. The aim of this study is to investigate the frequency of testicular tumor in patients with infertility. Methods and Materials: 954 male patients, who presented to the urology polyclinic with a complaint of infertility or who were consulted from gynecology and obstetrics clinics with male infertility factor, between August 2015 and August 2018, were evaluated retrospectively. Medical records, physical examination and spermiogram findings were considered. The data of the patients who were diagnosed with testicular mass through physical examinations and underwent radical orchiectomy, were analyzed. Results: Of 954 evaluated male patients with a mean age of 31,6 (30-35) years, four had right testicular mass and one had left testicular mass. None of these patients had a medical record of undescended testicle. Tumor markers of all patients were normal and neither lymph node nor organ metastasis were observed through computerized tomography analysis. 3 of 5 patients had oligospermia and 2 had azoospermia. Pathologic diagnosis of inguinal orchiectomy materials were reported as pure seminoma in all patients. Conclusions: Especially in infertile male patients, when performing testicular examination it should be taken into consideration that there is an increased risk of testicular tumor. It is considered that informing individuals of this population about doing an examination of testicle is important in early diagnosis.